Chachra Alisha, Gunashekar Satheesh, Kumar Ajit, Thakur Nitish, Jagath Arun
Department of Anaesthesia, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Indian J Anaesth. 2023 Dec;67(12):1061-1070. doi: 10.4103/ija.ija_478_23. Epub 2023 Dec 13.
Studies have suggested that anaesthetic agents have modulatory effects on the immune system, leading to cancer recurrence. The association between colorectal cancer (CRC) recurrence and anaesthesia is still unclear. Therefore, this systematic review aimed to determine the association between the recurrence of CRC after surgery and anaesthesia.
A database search of PubMed, Cochrane, Embase, and Scopus was performed for articles on the recurrence of CRC after surgeries under general anaesthesia (GA) and regional anaesthesia (RA), published between January 2002 and January 2023. Qualitative and risk-of-bias assessment of retrospective studies was performed using the Newcastle-Ottawa scale (NOS). Synthesis Without Meta-analysis guidelines were used to report data synthesis. The primary outcome was cancer recurrence, and the secondary outcomes were disease-free survival (DFS) and overall survival. The standardised metric to represent data synthesis was the median hazard ratio (HR). Evidence quality was rated as per GRADE pro-GDT.
A total of six retrospective cohorts were identified through the literature search for inclusion. The risk of bias was low in all studies and was rated good quality as per the NOS. The pooled risk ratio for cancer recurrence in the two studies was 1.04, 95% confidence interval 0.98-1.10 ( = 0.20). The median HR for cancer recurrence was 0.895. DFS was not statistically significant with GA or RA, with a median HR of 1.06.
No conclusive association was found between regional anaesthesia and colorectal cancer recurrence. However, due to a lack of studies reporting cancer recurrence and less data for comparison and different intervention groups, a conclusive association cannot be made.
研究表明麻醉药物对免疫系统具有调节作用,可导致癌症复发。结直肠癌(CRC)复发与麻醉之间的关联仍不明确。因此,本系统评价旨在确定手术治疗后CRC复发与麻醉之间的关联。
对PubMed、Cochrane、Embase和Scopus数据库进行检索,查找2002年1月至2023年1月期间发表的关于全身麻醉(GA)和区域麻醉(RA)下手术治疗后CRC复发的文章。使用纽卡斯尔-渥太华量表(NOS)对回顾性研究进行定性和偏倚风险评估。采用非Meta分析的综合指南报告数据综合情况。主要结局为癌症复发,次要结局为无病生存期(DFS)和总生存期。代表数据综合情况的标准化指标为中位风险比(HR)。根据GRADE pro-GDT对证据质量进行分级。
通过文献检索共纳入6个回顾性队列研究。所有研究的偏倚风险均较低,根据NOS评定为高质量。两项研究中癌症复发的合并风险比为1.04,95%置信区间为0.98 - 1.10( = 0.20)。癌症复发的中位HR为0.895。GA或RA对DFS无统计学显著影响,中位HR为1.06。
未发现区域麻醉与结直肠癌复发之间存在确凿关联。然而,由于缺乏报告癌症复发的研究,可供比较的数据较少且干预组不同,因此无法得出确凿的关联结论。